Erratum to "Effect of the 252A>G polymorphism of the lymphotoxin-α gene on inflammatory markers of response to cigarette smoking in Korean healthy men" [Clinica Chimica Acta 377 (2007) 221-227] (DOI:10.1016/j.cca.2006.10.002);Effect of the 252A>G polymorphism of the lymphotoxin-α gene on inflammatory markers of response to cigarette smoking in Korean healthy men

Clinica Chimica Acta

Volumn 377, Issue 1-2, 2007, Pages 221-227

  Jang, Yangsoo ^a,b   Koh, Soo Jeong ^b   Kim, Oh Yoen ^b   Kim, Byoung Keuk ^c   Choi, Donghoon ^a   Hyun, Yae Jung ^b   Kim, Hyae Jin ^b   Chae, Jey Sook ^b   Lee, Jong Ho ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c National Health Insurance Corporation   (South Korea)

Author keywords

252A>G polymorphism; Cigarette smoking; Inflammatory markers; Lymphotoxin gene

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 6; LIPID; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; DNA POLYMORPHISM; DRUG URINE LEVEL; GENE INTERACTION; GENOTYPE; HUMAN; INFLAMMATION; KOREA; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; URINARY EXCRETION;

EID: 33845383318     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.12.014     Document Type: Erratum

References (34)

1. Gensini G.F., Comeglio M., and Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J 19 Suppl A (1998) A53-A61
2. Tappia P.S., Troughton K.L., Langley-Evans S.C., and Grimble R.F. Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci 88 (1998) 485-489
3. de Maat M.P., Pietersma A., Kofflard M., Sluiter W., and Kluft C. Association of plasma fibrinogen concentrations with coronary artery disease, smoking and inflammatory markers. Atherosclerosis 121 (1996) 185-191
4. 2-isoprostane formation in elderly men. Atherosclerosis 181 (2005) 201-207
5. Sonmez K., Akcay A., Akcakoyun M., and Turan F. Distribution of risk factors and prophylactic drug usage in Turkish patients with angiographically established coronary artery disease. J Cardiovasc Risk 9 (2002) 199-205
6. Talmud P.J., Hawe E., and Miller G.J. Analysis of gene-environment interaction in coronary artery disease: lipoprotein lipase and smoking as examples. Ital Heart J 3 (2002) 6-9
7. McGuire W., Hill A.V., Allsopp C.E., Greenwood B.M., and Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371 (1994) 508-510
8. Herrmann S.M., Ricard S., Nicaud V., et al. Polymorphism of the tumor necrosis factor-α gene, coronary heart disease and obesity. Eur J Clin Invest 28 (1998) 59-66
9. Femandez-Real J.M., Gutierrez C., Ricart W., et al. The TNF-α gene NcoI polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin concentrations. Diabetes 46 (1997) 1468-1472
10. Skoog T., van't Hooft F.M., Kallin B., et al. A common functional polymorphism (C>-A substitution at position-863) in the promoter region of the tumor necrosis factor-α (TNF-α) gene associated with reduced circulating concentrations of TNF-α. Hum Mol Genet 8 (1999) 1443-1449
11. Gander M.L., Fischer J.E., Maly F.E., and von Kanel R. Effect of the G-308A polymorphism of the tumor necrosis factor (TNF)-α gene promoter site on plasma concentrations of TNF-α and C-reactive protein in smokers: a cross-sectional study. BMC Cardiovasc Disord 14 (2004) 4-17
12. Campbell R.D., and Trowsdale J. Map of the human MHC. Immunol Today 14 (1993) 349-352
13. Pociot F., Briant L., Jongeneel C.V., et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-α by mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23 (1993) 224-231
14. Stuber F., Petersen M., Bokelmann F., and Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 24 (1996) 381-384
15. Churg A., Dai J., Tai H., Xie C., and Wright J.L. Tumor necrosis factor-α is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 166 (2002) 849-854
16. Ozaki K., Ohnishi Y., Iida A., et al. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nat Genet 32 4 (2002) 650-654
17. Risley P., Jerrard-Dunne P., Sitzer M., Buehler A., von Kegler S., and Markus H.S. Promoter polymorphism in the endotoxin receptor (CD14) is associated with increased carotid atherosclerosis only in smokers: the Carotid Atherosclerosis Progression Study (CAPS). Stroke 34 (2003) 600-604
18. Ortlepp J.R., Metrikat J., Vesper K., et al. The interleukin-6 promoter polymorphism is associated with increased leukocyte, lymphocyte, and monocyte counts and reduced physical fitness in young healthy smokers. J Mol Med 81 (2003) 578-584
19. DeGraba T.J. Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaque. Neurology 49 (1997) S515-S519
20. Nadif R., Jedlicka A., Mintz M., Bertrand J.P., Kleeberger S., and Kauffmann F. Effect of TNF and LTA polymorphisms on biological markers of response to oxidative stimuli in coal miners: a model of gene-environment interaction. J Med Genet 40 2 (2003) 96-103
21. Bermudez E.A., Rifai N., Buring J., Manson J.E., and Ridker R.M. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22 10 (2002) 1668-1673
22. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
23. Volpato S., Guralnik J.M., Ferrucci L., et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 103 (2001) 947-953
24. Harris T.B., Ferrucci L., Tracy RP., et al. Associations of increased interleukin-6 and C-reactive protein concentrations with mortality in the elderly. Am J Med 106 (1999) 506-512
25. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115 5 (2005) 911-919
26. Berg A.H., and Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 9 (2005) 939-949
27. Jerrard-Dunne P., Sitzer M., Risley P., Buehler A., von Kegler S., and Markus H.S. Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke 35 11 (2004) 2438-2443
28. van den Berg R., Haenen G.R., van den Berg H., and Bast A. Nuclear factor-kappaB activation is higher in peripheral blood mononuclear cells of male smokers. Environ Toxicol Pharmacol 9 4 (2001) 147-151
29. Willoughby D.A. Heberden Oration, 1974. Human arthritis applied to animal models. Towards a better therapy. Ann Rheum Dis 34 6 (1975) 471-478
30. Montuschi P., Collins J.V., Ciabattoni G., et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 162 (2000) 1175-1177
31. Keaney Jr. J.F., Larson M.G., Vasan R.S., et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23 3 (2003) 434-439
32. Basu S., and Helmersson J. Factors regulating isoprostane formation in vivo. Antioxid Redox Signal 7 (2005) 221-235
33. Padovani J.C., Pazin-Filho A., Simoes M.V., Marin-Neto J.A., Zago M.A., and Franco R.F. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 100 4 (2000) 263-269
34. Bull D.J., Leeson C.P., Montgomery H.E., et al. The effect of the interleukin-6-174G>C promoter gene polymorphism on endothelial function in healthy volunteers. Eur J Clin Invest 32 3 (2002) 153-157